CSNK1A1 and acute myeloid leukemia: Pharmacologic inhibition of CK1α using D4476, a pan-CK1 inhibitor, or CK1α knockdown via lentivirus-mediated shRNA, suppressed proliferation and clone formation by enhancing autophagic flux and apoptosis in both AML cell lines and patient blast cells18.